What is BPC-157? Research Overview & Mechanism
September 18, 2026 · By My Store 3 Admin
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. Consisting of 15 amino acids, it has been the subject of extensive preclinical research owing to its apparent tissue-protective and regenerative properties.
This article provides a research-focused overview of BPC-157, its proposed mechanisms, and the current state of scientific investigation. All Bloom Vitality products are supplied strictly for in vitro laboratory and research use only.
Molecular Profile
BPC-157 has the amino acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is stable in human gastric juice, which distinguishes it from many other peptides that are rapidly degraded in acidic environments. This stability has made it a practical candidate for research across multiple administration routes in animal models.
Proposed Mechanisms
Research to date has identified several potential mechanisms through which BPC-157 may exert its effects:
- Angiogenesis modulation — BPC-157 appears to upregulate VEGFR2 expression and promote the formation of new blood vessels, which may support tissue repair processes.
- Nitric oxide system interaction — Studies suggest BPC-157 influences the NO-system, potentially contributing to its cytoprotective effects on endothelial cells.
- Growth hormone receptor interaction — Research indicates BPC-157 may interact with the GH-receptor signalling pathway, which could be relevant to its observed effects on tendon and bone healing in animal models.
- Gut-brain axis activity — Given its gastric origin, BPC-157 has been studied in the context of gastrointestinal integrity and gut-brain communication.
Areas of Preclinical Research
The majority of BPC-157 research has been conducted in rodent models. Key areas of investigation include:
- Tendon and ligament repair
- Muscle healing following injury
- Gastrointestinal mucosal protection
- Bone healing and regeneration
- Neurological protection and dopamine system modulation
- Inflammatory response modulation
Research Status
As of 2026, BPC-157 remains at the preclinical stage. The majority of published research consists of animal studies, predominantly in rats and mice. No large-scale randomised controlled trials in humans have been completed. The compound is not approved as a therapeutic agent in any major jurisdiction.
Its stability, apparent tolerability in animal models, and breadth of investigated mechanisms make it one of the more extensively studied synthetic peptides in preclinical literature.
BPC-157 Research Material
Bloom Vitality supplies BPC-157 10mg as a lyophilised research vial, independently third-party tested for purity and potency. A batch-specific Certificate of Analysis is available on request via our Testing & Quality page. Batch documentation is available via Certificates & Documentation.
We also supply a BPC-157 + TB-500 Blend for researchers investigating combined protocols.
Further Reading
- BPC-157 Research: Evidence Quality & Study Landscape — a critical appraisal of the preclinical literature, study concentration, and what the evidence does and does not establish
- Evaluating Peptide Purity: CoAs, HPLC & What the Data Tells You — how to assess analytical documentation when sourcing research compounds
- BPC-157 + TB-500 Blend: Combined Research Overview
For research and laboratory use only. This article is provided for informational purposes and does not constitute medical advice.